Continuous Transdermal Nitroglycerin No Aid for Hot Flashes
FRIDAY, June 9, 2023 -- Uninterrupted transdermal nitroglycerin (NTG) therapy does not offer sustained benefit for hot flashes, according to a study published online June 5 in JAMA Internal Medicine.
Alison J. Huang, M.D., from the University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 9, 2023 Category: Pharmaceuticals Source Type: news
Nitroglycerin Patches Do Not Improve Menopause Symptoms Nitroglycerin Patches Do Not Improve Menopause Symptoms
A promising nonhormonal therapy failed to improve the frequency and severity of hot flashes in a new study.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 6, 2023 Category: Cardiology Tags: Ob/Gyn & Women ' s Health News Source Type: news
Could a Nitroglycerin Patch Ease Hot Flashes?
TUESDAY, June 6, 2023 -- A new study on using nitroglycerin patches to help women with frequent hot flashes caused by menopause has delivered mixed results.
The benefits of wearing these patches — long used as chest pain medication — were... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 6, 2023 Category: General Medicine Source Type: news
Nitroglycerin Patches Flop for Cooling Hot Flashes
(MedPage Today) -- Continuous transdermal nitroglycerin did not lead to sustained improvements in hot flashes for perimenopausal and postmenopausal women, the randomized FRAN trial showed.
Over 5 weeks, the estimated change in any hot flash frequency... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - June 5, 2023 Category: Endocrinology Source Type: news
Heart patients face another medication shortage. This time it's nitroglycerin tablets
A nationwide shortage of a fast-acting heart medication is getting worse as tight supplies of one form of the drug have depleted stock of another. (Source: CBC | Health)
Source: CBC | Health - May 11, 2023 Category: Consumer Health News Tags: News/Canada/Calgary Source Type: news
Shortage of key heart medication — nitroglycerin spray — sparks worry in Alberta
A tight supply of a fast-acting heart medication is causing concern for Alberta health-care providers as a shortage looms across the country. (Source: CBC | Health)
Source: CBC | Health - March 21, 2023 Category: Consumer Health News Tags: News/Canada/Calgary Source Type: news
Nitroglycerin: How An Explosive Became a Cardiac Drug Nitroglycerin: How An Explosive Became a Cardiac Drug
Alfred Nobel may be famous for inventing dynamite but it was the earlier discovery of nitroglycerin by Ascanio Sobrero that ultimately led to our use of nitrates in cardiovascular medicine.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - February 6, 2023 Category: Intensive Care Tags: Hospital Medicine News Source Type: news
Minitran (Nitroglycerin Transdermal Delivery System) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 1, 2022 Category: Drugs & Pharmacology Source Type: news
Nitro Spray Recalled Due to Possible Defective Delivery System Nitro Spray Recalled Due to Possible Defective Delivery System
Padagis US LLC says there is a remote risk that the product may not properly dispense nitroglycerin, rendering the medicine potentially ineffective.News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 28, 2021 Category: Cardiology Tags: Cardiology News Alert Source Type: news
Padagis Issues Voluntary Nationwide Recall for Nitroglycerin Lingual Spray Due to a Possible Defective Delivery System
December 27, 2021 – Padagis US LLC announced today it has issued a voluntary nationwide recall to the consumer/user level of the lots of Nitroglycerin Lingual Spray listed in the table below. Out of an abundance of caution, this product is being recalled from the market due to a complaint received t (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 27, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
MR ASAP: No Benefit of Prehospital Nitroglycerin in Stroke MR ASAP: No Benefit of Prehospital Nitroglycerin in Stroke
Giving transdermal nitroglycerin to stroke patients in the ambulance within 3 hours of symptom onset was not shown to be of any benefit in the MR ASAP trial, which was stopped early owing to futility.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 7, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Transderm Nitro (Nitroglycerin) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 27, 2021 Category: Drugs & Pharmacology Source Type: news
On nitroglycerin, cardiovascular homeostasis and...bam, migraine!
(International Headache Society) Researchers in Leiden, The Netherlands, found an exaggerated cardiovascular response to nitroglycerin infusion in migraine patients, suggesting an elevated systemic sensitivity to this compound in this population. Also, corroborating previous studies, nitroglycerin was shown to be a consistent migraine-provoking substance. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 27, 2019 Category: International Medicine & Public Health Source Type: news
Minitran (Nitroglycerin Transdermal Delivery System) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 15, 2019 Category: Drugs & Pharmacology Source Type: news
Advanced Pharma, Inc. D/B/A Avella of Houston Issues Voluntary Nationwide Recall of All Unexpired Nitroglycerin Injection In 5% Dextrose USP Products Produced At Its Houston Location From March 3, 2017 Through May 31, 2017 Due To Sub-Potency
Advanced Pharma, Inc. d/b/a Avella of Houston ( “Advanced Pharma”) is voluntarily recalling all unexpired lots of Nitroglycerin products that were produced at Advanced Pharma’s Houston location between March 3, 2017 and May 31, 2017 to the hospital/user level. The recall is being issued based on laboratory test results indicating a lower t han expected potency on certain lots of compounded NitroGlycerin Injection which would lead to a lower dose being administered. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 25, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
